Today’s top gainers include the company Biogen Inc. (NASDAQ:BIIB) which is in the industry Biotechnology, gaining -0.17% today. In the last week its performance is -0.02%, and 19.71% for the past quarter. Currently, Biogen Inc., BIIB has a target price of 333.6, so today’s gain of -0.17% is a significant step towards its target price. The GAP today is therefore -0.79%.
Biogen Inc. (NASDAQ:BIIB), has a market cap of 72316.97, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 88.60%.
At the current price of 313.94, it has a dividend yield of *TBA, and its target price is 333.6. This is with a profit margin of 34.00%, and total debt/equity of 0.57. Biogen Inc. (NASDAQ:BIIB) has a P/E of 18.36, as well as a forward P/E of 14.94.
With a current EPS of 17.13, and a forecasted EPS growth for next year at 5.40%,Biogen Inc. (NASDAQ:BIIB) has had a EPS growth for the past five years at 31.30%. For the next five years EPS growth is projected to be 9.50%.
Performance for the year is -0.71%. Since its IPO date on 9/17/1991, the total performance to date is 2.66%.
Volume today for Biogen Inc. (NASDAQ:BIIB), is 993671, while its average volume is 2110.38. Whilst the total gain today was -0.17%, it did have a day high of -5.91%.
Volatility for this week has been at 2.04%, and 2.65% for the month. The 52-week low for Biogen Inc., BIIB has been 40.77%, while the 52-week-high has reached -5.91%.
Looking at its return of investments, which is 23.50%, and its return on assets is 18.50%. Biogen Inc. (NASDAQ:BIIB) has an operating margin of 47.90%. With a sales growth of 11.70% quarter over quarter. Bearing in mind that Biogen Inc., BIIB is in the sector Healthcare, its long-term debt/equity is 0.57, and has a current ratio of 3 and 2.6 for quick ratio.
So what is the value of Biogen Inc.? Well its PEG is 1.93, and the P/S is 6.43, along with a P/B of 6.04. Meanwhile it has a p/cash of 19.05.